marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Greenwich LifeSciences Financial Statements 2011-2024 | GLSI
Annual Financial Statements Greenwich LifeSciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
183 M | 170 M | 256 M | 330 M | - | - | - | - | - | - | - | - | - |
Shares |
12.8 M | 12.8 M | 13.1 M | 8.79 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
14.3 | 13.2 | 19.5 | 31.3 | - | - | - | - | - | - | - | - | - |
Net Income |
-8.89 M | -7.83 M | -4.57 M | -1.86 M | -3.43 M | -1.69 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-9.33 M | -8.04 M | -4.6 M | -1.86 M | -3.43 M | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-9.33 M | -8.04 M | -4.6 M | -1.86 M | -3.42 M | -1.69 M | - | - | - | - | - | - | - |
Operating Expenses |
9.33 M | 8.04 M | 4.6 M | 1.86 M | 3.43 M | 1.69 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.63 M | 1.56 M | 1.04 M | 806 K | 819 K | 420 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Greenwich LifeSciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
13.1 M | 12.9 M | 12.9 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 13 M | 13.1 M | 13 M | 12.9 M | 12.8 M | 12.7 M | 8.79 M | 8.59 M | 8.5 M | 8.46 M | 292 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-2.67 M | -2.61 M | -2.47 M | - | -2.39 M | -1.63 M | -2.12 M | - | -2.32 M | -746 K | -1.97 M | - | -863 K | -750 K | -597 K | - | -257 K | -210 K | -245 K | - | -336 K | -2.6 M | -149 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.73 M | -2.66 M | -2.54 M | - | -2.5 M | -1.75 M | -2.24 M | - | -2.38 M | -773 K | -1.99 M | - | -867 K | -753 K | -601 K | - | -257 K | -210 K | -245 K | - | -336 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-2.73 M | -2.66 M | -2.54 M | - | -2.5 M | -1.75 M | -2.24 M | - | -2.38 M | -773 K | -1.99 M | - | -867 K | -753 K | -601 K | - | -257 K | -210 K | -245 K | - | -336 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.73 M | 2.66 M | 2.54 M | - | 2.5 M | 1.75 M | 2.24 M | - | 2.38 M | 773 K | 1.99 M | - | 867 K | 753 K | 601 K | - | 257 K | 210 K | 245 K | - | 336 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
437 K | 354 K | 343 K | - | 345 K | 368 K | 413 K | - | 660 K | 140 K | 328 K | - | 210 K | 197 K | 319 K | - | 98.8 K | 59.6 K | 94.8 K | - | 51.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency